Bio


I'm a future physician-scientist working at the intersection of statistics, machine learning, and neural signal processing. As part of the Harvard/MIT MD-PhD Program, I recently completed my PhD in Medical Engineering & Medical Physics (MEMP) through the Harvard-MIT Health Sciences and Technology (HST) Program.

Currently I'm a postdoctoral fellow in pediatric anesthesiology with Dr. Jennifer Rabbitts and Dr. Cornelius Groenewald at Stanford, where I apply causal inference methods to large-scale electronic health record data to estimate how intraoperative decisions shape long-term postoperative pain and opioid outcomes in children.

I'm also interested in medical education and administration, particularly supporting minority populations such as LGBTQIA+ and Vietnamese communities. Outside of science, I bring a background in graphic design, marketing, and brand development for technology companies, universities, and non-profits.

Honors & Awards


  • First Place - Stanford Graduate School of Business Healthcare Pitch Competition, Stanford Graduate School of Business (2026)
  • Harvard Medical School Soma Weiss Award for Excellence in Research, Harvard Medical School (2026)
  • Stanford Anesthesia Research Awards - Honorable Mention for Best Research Abstract, Stanford University Department of Anesthesiology, Perioperative and Pain Medicine (2026)
  • NIH F30 MD-PhD Fellowship Grant, NIH: National Institute on Drug Abuse (NIDA) (2025 - 2026)
  • SAE International Doctoral Engineering Scholarship, SAE (2025)
  • Stanford Anesthesia Research Awards - Best Clinical Science Abstract, Stanford University Department of Anesthesiology, Perioperative and Pain Medicine (2025)
  • Stanford SPARK Program Award in Excellence, Stanford SPARK Program (2025)
  • Point Foundation Scholar, Point Foundation (2024, 2025)
  • Stanford SPARK Program Scholar, Stanford SPARK Program (2024 - 2026)
  • Harvard-MIT HST Neuroimaging Training Program NIH T32 Grant, NIH: National Institute of Biomedical Imaging and Bioengineering (NIBIB) (2023 - 2025)
  • MIT Institute of Medical Engineering & Sciences (IMES) Prince Fellowship, MIT Institute of Medical Engineering & Sciences (IMES) (2022 - 2023)
  • MIT HST Roger G. Mark Outstanding Service Award, Harvard/MIT Health Sciences and Technology (HST) Program (2021)
  • Harvard-MIT MD-PhD NIH Medical Scientist Training Program (MSTP) Grant, National Institutes of Health (NIH): National Institute of General Medical Sciences (NIGMS) (2020 - 2030)
  • LGBT Foundation Scholar, LGBT Foundation (2020 - 2024)
  • Harrison D. Stalker Senior Thesis Award in Biology, Washington University in St. Louis (2019)
  • Latin Honors: Summa Cum Laude, Washington University in St. Louis (2019)
  • Scholar in Arts & Sciences, Washington University in St. Louis (2018)

Professional Education


  • MD, Harvard/MIT Health Sciences and Technology (HST) Program
  • PhD, Harvard/MIT Health Sciences and Technology (HST) Program, Biomedical Engineering (2026)
  • MS, Washington University in St. Louis, Systems Science & Mathematics (2020)
  • BA, Washington University in St. Louis, Neuroscience & Electrical Engineering (2019)

Stanford Advisors


Lab Affiliations


All Publications


  • Rethinking the Integration of Artificial Intelligence Into Surgery: Centralized Risk Assessment for System-Level Impact. Annals of surgery open : perspectives of surgical history, education, and clinical approaches Mather, R. V., Kunitake, H., Purdon, P. L. 2026; 7 (2): e661

    View details for DOI 10.1097/AS9.0000000000000661

    View details for PubMedID 42344479

    View details for PubMedCentralID PMC13290149

  • Association of peripheral nerve blocks with increased postoperative pain and opioid use in orthopaedic surgery: a single-centre retrospective cohort study. British journal of anaesthesia Chung, A. R., Mather, R. V., Gutierrez, R., Liu, R., Leung, C. F., Zhang, M., Santa Cruz Mercado, L. A., Houle, T. T., Bittner, E. A., Purdon, P. L. 2025

    Abstract

    Peripheral nerve blocks have become popular in orthopaedic surgeries to improve acute postoperative pain. However, studies are mixed on their effectiveness in decreasing postoperative opioid consumption. A more comprehensive analysis is necessary to understand if peripheral nerve blocks reduce postoperative opioid exposure and risk for opioid dependence.This retrospective cohort study evaluated electronic health record data for adults undergoing orthopaedic surgery with general anaesthesia from 2016 to 2020 at the Massachusetts General Hospital. Linear models were fitted on propensity-weighted data to characterise the association between single injection peripheral nerve blocks and clinical outcomes. Our primary outcomes were maximum pain score and cumulative opioid dose, quantified in morphine milligram equivalents, administered in the PACU. Post-discharge outcomes associated with pain and opioid consumption were also evaluated.Among 22 956 patients, peripheral nerve block administration was associated with lower maximum pain scores and lower probability of opioid administration in the PACU. However, it was associated with higher maximum pain scores and a 22.7% increase in opioid consumption during the hospital stay. Peripheral nerve blocks were associated with an increase in opioid prescriptions at 30 days after discharge, but no increase at 90 or 180 days, and with decreased chronic pain diagnoses 1 yr after operation.Although single injection peripheral nerve blocks were effective in reducing immediate postoperative pain and opioid consumption, they were associated with greater opioid consumption that could increase the risk for opioid dependence. Standardised protocols to mitigate the risk for rebound pain could help minimise postoperative opioid exposure.

    View details for DOI 10.1016/j.bja.2025.05.030

    View details for PubMedID 40610285

  • Substance Use and Pain Curriculum Innovation: Establishing a Student-Faculty Partnership for Curricular Change ACADEMIC MEDICINE Mather, R., Jack, H. E., Warren, K. E., Comrie, C., Li, S., Liu, M., Lynn-Green, E., Moore, S., Oles, W., Saberi, S. A., Jarvie, E. J., Koka, A., McGuire, P., Barreveld, A. M., Connery, H. S., Griswold, T. 2025; 100 (7): 790-795

    Abstract

    The opioid overdose crisis had progressed broadly in the United States, with a 21% increase from 2016 to 2017, and specifically in Massachusetts, with a peak rate of 1,374 deaths in 2016. In 2016, students and faculty at Harvard Medical School (HMS) established the Substance Use and Pain Curriculum Committee (SUPCC) to expand substance use and pain education. However, faculty capacity, financial resources, and administrative support were insufficient to implement changes across all phases of the medical school curriculum.The HMS SUPCC restructured in 2021 to put students at the forefront of curricular development. This restructuring was done through 3 main innovations: (1) establishment of a student-centered committee structure, ensuring that curricular changes are centered on student interests and needs; (2) student-led curricular development and implementation, reducing faculty workload; and (3) focus on clinically relevant teaching and opportunities to practice learned skill sets.This student-centered structure facilitated the expansion of the addiction and pain medicine curriculum to more than 30 hours of teaching by 2024. Examples of student-driven initiatives include development of an opioid use disorder management practicum equivalent to the Drug Enforcement Agency X-waiver, increased medical student access to naloxone through a hospital partnership, and integration of case-based opioid use disorder and pain medicine didactics into the clerkship year.Although this work has established a longitudinal curriculum across all medical training stages, more must be done in clerkship rotations to help students apply their substance use and pain education in the clinical setting. The HMS SUPCC is working to incorporate teaching on nonopioid substances, such as alcohol, cannabis, and ketamine; provide longitudinal clinical experiences so students learn to care for patients with substance use disorder and chronic pain from short-term intervention to long-term recovery; and develop surveys to quantitatively and qualitatively measure curriculum outcomes.

    View details for DOI 10.1097/ACM.0000000000006018

    View details for Web of Science ID 001517194000002

    View details for PubMedID 40048728

    View details for PubMedCentralID PMC12197844

  • Intraoperative Frontal EEG Alpha Power is Associated with Post-Operative Mortality and Other Adverse Outcomes. Anesthesiology Mather, R. V., Nipp, R. D., Balanza, G., Stone, T. A., Gutierrez, R., Raje, P., Higuchi, M., Liu, R., Santa Cruz Mercado, L. A., Bittner, E. A., Kunitake, H., Purdon, P. L. 2024

    Abstract

    With estimated global post-operative mortality rates at 1-4% leading to approximately 3-12 million deaths per year, an urgent need exists for reliable measures of perioperative risk. Existing approaches suffer from poor performance, place a high burden on clinicians to gather data, or do not incorporate intraoperative data. Prior work demonstrated that intraoperative anesthetics induce prefrontal EEG oscillations in the alpha band (8-12Hz) that correlate with post-operative cognitive outcomes.We analyzed a retrospective cohort of 1,081 patients undergoing surgery with general anesthesia at Massachusetts General Hospital with intraoperative EEG recordings. The association between EEG alpha power and adverse outcomes were characterized using statistical models that were fitted on propensity weighted data. Our primary outcome was post-operative mortality, measured from date of surgery to date of death or last follow-up. Secondary outcomes included mortality within pre-specified time windows (30-days, 90-days, 180-days, and 1-year), hospital and PACU lengths of stay, discharge to long-term care, and 30-day hospital readmission.Alpha power was associated with mortality risk (HR = 0.92, 95% CI:[ 0.85, 0.99], p=0.039). Within specified time windows, alpha power was associated with 30-day mortality (OR = 0.81, 95% CI: [0.66, 0.95], p=0.010), 90-day mortality (OR = 0.68, 95% CI: [0.55, 0.79], p<0.001), 180-day mortality (OR = 0.75, 95% CI: [0.66, 0.83], p<0.001), and 1-year mortality (OR = 0.85, 95% CI: [0.79, 0.91], p<0.001). Additionally, alpha power was associated with discharge to long-term care (OR = 0.91, 95% CI: [0.86, 0.96], p<0.001). We did not find significant associations among alpha power and 30-day readmission and hospital or PACU lengths of stay.Intraoperative EEG alpha power is independently associated with post-operative mortality and adverse outcomes, suggesting it could represent a broad measure of post-operative physical resilience and provide clinicians with a low-burden, personalized measure of post-operative risk.

    View details for DOI 10.1097/ALN.0000000000005315

    View details for PubMedID 39601585

  • Development and prospective validation of postoperative pain prediction from preoperative EHR data using attention-based set embeddings. NPJ digital medicine Liu, R., Gutiérrez, R., Mather, R. V., Stone, T. A., Santa Cruz Mercado, L. A., Bharadwaj, K., Johnson, J., Das, P., Balanza, G., Uwanaka, E., Sydloski, J., Chen, A., Hagood, M., Bittner, E. A., Purdon, P. L. 2023; 6 (1): 209

    Abstract

    Preoperative knowledge of expected postoperative pain can help guide perioperative pain management and focus interventions on patients with the greatest risk of acute pain. However, current methods for predicting postoperative pain require patient and clinician input or laborious manual chart review and often do not achieve sufficient performance. We use routinely collected electronic health record data from a multicenter dataset of 234,274 adult non-cardiac surgical patients to develop a machine learning method which predicts maximum pain scores on the day of surgery and four subsequent days and validate this method in a prospective cohort. Our method, POPS, is fully automated and relies only on data available prior to surgery, allowing application in all patients scheduled for or considering surgery. Here we report that POPS achieves state-of-the-art performance and outperforms clinician predictions on all postoperative days when predicting maximum pain on the 0-10 NRS in prospective validation, though with degraded calibration. POPS is interpretable, identifying comorbidities that significantly contribute to postoperative pain based on patient-specific context, which can assist clinicians in mitigating cases of acute pain.

    View details for DOI 10.1038/s41746-023-00947-z

    View details for PubMedID 37973817

    View details for PubMedCentralID 8369227

  • Centering Patient Health Over Legal Status: A Student-Driven Cannabis Risk Stratification Framework for Undergraduate Medical Education SUBSTANCE USE & ADDICTION JOURNAL Liu, J. J., Moore, S., Zhai, X., Mather, R., Oles, W., Cerda, I., McGuire, P., Connery, H. S. 2026: 29767342261489469

    Abstract

    Cannabis use is increasing worldwide, both for evidence-supported indications and conditions with limited evidence such as anxiety, depression, and chronic pain. Although incongruence between state and federal cannabis laws has delayed expanding cannabis education within medical schools, patients will continue to use cannabis and physicians must be prepared to counsel them. Therefore, evidence-informed cannabis education is needed to prepare medical students to discuss cannabis use using a patient-centered and harm reduction-oriented framework rather than relying on legal status alone.We convened a student-faculty working group in addiction psychiatry, addiction medicine, and pain medicine to develop a practical teaching framework grounded in peer-reviewed literature on cannabis-related risks, patterns of use, and patient counseling. We reviewed existing cannabis curricula and identified points within medical school courses where this content could be incorporated without major restructuring.We developed a Cannabis Use Risk Stratification Framework intended to help medical students organize cannabis-related health benefits and risks into teachable categories based on use-related (frequency, potency, and route) and patient-related (age, comorbidities, and functional impact) factors. The framework is taught in two 1-hour sessions: a preclinical lecture introducing the framework, and a preclerkship session using cases and simulations to apply it. By centering discussion on patient health and harm reduction rather than legality alone, the framework remains applicable across jurisdictions and provides students with a role in clinical encounters: obtaining a cannabis history, identifying benefits and potential risk factors, and delivering brief, educational counseling to promote shared decision-making.This framework addresses a foundational gap in undergraduate medical education by providing an educational approach to discussing cannabis-related benefit and risk that is adaptable across institutions, resource settings, and jurisdictions. The risk categories are pragmatic and teachable, offering learners a conceptual framework for recognizing when cannabis use warrants monitoring, brief counseling, or escalation to formal intervention.

    View details for DOI 10.1177/29767342261489469

    View details for Web of Science ID 001907180900001

    View details for PubMedID 42899460

  • A Prospective Study Characterizing Cognitive Function in Patients with Inflammatory Bowel Disease. Clinical and translational gastroenterology Raje, P., Stone, T. A., Alkourabi, J., Mather, R. V., Liu, R., Higuchi, M., Nipp, R. D., Purdon, P. L., Kochar, B., Kunitake, H. 2026

    Abstract

    Inflammatory bowel disease (IBD) may be associated with cognitive impairment. Cognitive decline is also linked to weaker anesthesia-induced alpha wave electroencephalographic (EEG) signals. We aimed to characterize the associations between cognition and EEG alpha power in patients with IBD.In this prospective cohort study, patients with IBD and controls undergoing diagnostic or screening colonoscopies underwent preprocedural cognitive testing using the tablet-based Brain Health Assessment (BHA), intraprocedural EEG monitoring, and follow-up testing. Primary outcomes were BHA scores and EEG alpha power. Secondary outcomes included within-participant changes in cognitive performance.We enrolled 40 patients with IBD and 42 control patients. Fifteen IBD patients and 17 controls completed follow-up cognitive testing 6-18 months after endoscopy. Patients with IBD were younger (mean age 42 vs. 56 years, p<0.001), more likely to screen positively for depression (p=0.004), and had fewer years of education (16.2 vs. 17.3 years, p=0.03). Fifteen IBD patients had active endoscopic inflammation. Adjusting for demographics, education level, and depression, EEG alpha power did not differ between groups. Median BHA scores indicated moderate likelihood of cognitive impairment in both groups. However, controls demonstrated improved within-participant follow-up performance (p<0.01), while IBD patients did not (p=0.16).IBD patients and controls demonstrate preprocedural cognitive impairment on BHA, but no differences in EEG alpha power. Lack of follow-up improvement in IBD patients may suggest lower baseline cognitive function while highlighting the importance of further investigations on cognition in this population.

    View details for DOI 10.14309/ctg.0000000000001036

    View details for PubMedID 41995584

  • Perioperative Optimization of Frail Older Adults Undergoing Elective Colorectal Surgery JOURNAL OF THE AMERICAN GERIATRICS SOCIETY Tang, R., Higuchi, M., Rudasill, S. E., Raje, P., Johnson, J. J., Mather, R. V., Lee, G. C., Russell, M., Pulluru, S., Cauley, C., Ricciardi, R., Kunitake, H. 2026; 74 (1): 153-159

    Abstract

    The Perioperative Optimization of Senior Health (POSH) clinic was established to address vulnerabilities and improve outcomes in frail older patients. This study describes the results of comprehensive perioperative optimization by the POSH interdisciplinary team (IDT) in patients who underwent colorectal surgery.Frail patients planned for colorectal surgery and enrolled in the POSH clinic (10/2021-09/2023) were retrospectively identified. Descriptive statistics were used to summarize the findings of preoperative geriatric assessment and postoperative outcomes. Outcomes were compared with a contemporary propensity-matched cohort using chi-squared analysis and two-sample t-tests for categorical and continuous variables, respectively.Thirty-six patients with a median age of 80 years and a mean Charlson Comorbidity Index of 6.11 were planned for colorectal surgeries, most commonly colectomy (62.1%) and ostomy reversal (20.7%). Twenty-nine patients underwent surgical management after interdisciplinary optimization in the POSH clinic. The most common interventions recommended included advance care planning (86.2%), physical therapy (55.2%), and medication management (34.5%). Postoperatively, 75% of patients were discharged home, and there were no mortalities within 90 days. There were no significant differences in postoperative outcomes when compared to a contemporary propensity-matched cohort. The remaining seven patients enrolled in POSH did not undergo surgical management after surgery was deemed inconsistent with their goals of care, and three of these patients expired within 1 year of evaluation in POSH.The POSH model provides high-risk patients with individualized risk stratification, comprehensive interdisciplinary strategies for risk mitigation, and alignment of care with patient goals. When elective colorectal surgery was within their goals of care, frail older adults safely underwent operative intervention after careful perioperative optimization. Future studies should include a mixed-method exploration of the patient perspective and a randomized controlled trial to quantify the impact of the POSH clinic on short- and long-term postoperative outcomes.

    View details for DOI 10.1111/jgs.70211

    View details for Web of Science ID 001636930900001

    View details for PubMedID 41387097

    View details for PubMedCentralID PMC13173556

  • Intraoperative Electroencephalogram Alpha Power Associated with Mortality: Reply. Anesthesiology Mather, R. V., Nipp, R. D., Balanza, G., Stone, T. A., Gutierrez, R., Raje, P., Higuchi, M., Liu, R., Mercado, L. A., Bittner, E. A., Kunitake, H., Purdon, P. L. 2025; 143 (5): 1425-1427

    View details for DOI 10.1097/ALN.0000000000005676

    View details for PubMedID 41085317

  • Bridging Medicine and Society-A Call to Expand the Pipeline of Physician-Social Scientists JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION Walensky, L. D., Mather, R., Meng, E. X. 2025; 333 (17): 1489-1490

    View details for DOI 10.1001/jama.2025.1308

    View details for Web of Science ID 001439223100001

    View details for PubMedID 40048198

    View details for PubMedCentralID PMC13078670

  • Chronic pain education: past, present, and future of psychedelics for the management of chronic pain PAIN MEDICINE Robinson, C. L., Solanki, P. K., Snyder, S., Amir, A., Barreveld, A., Mather, R., Cerda, I. H., Motoc, M., Chopra, H., Yong, R., Castellanos, J., Furnish, T., Kaye, A. D., Orhurhu, V., Emerick, T. 2025; 26 (4): 216-218

    View details for DOI 10.1093/pm/pnae124

    View details for Web of Science ID 001392701500001

    View details for PubMedID 39658247

    View details for PubMedCentralID PMC12225660

  • Electroencephalogram-Guided General Anesthesia in a Pediatric Patient With Alexander's Disease: A Case Report. A&A practice Zhang, M., Mather, R. V., Chung, A. R., Leung, C. F., Ramamurthi, R. J., Purdon, P. L. 2025; 19 (1): e01910

    Abstract

    In this case, the electroencephalogram (EEG) was used to guide anesthesia care for a pediatric patient with Alexander's Disease undergoing serial intrathecal injections. Previous procedures using a standard maintenance propofol dose of up to 225 µg/kg/min led to postanesthetic recovery times of over 6 hours, requiring a neurology consult for noncoherence. The EEG assisted in guiding maintenance propofol dosing to 75 µg/kg/min, decreasing postanesthetic wash-off and postanesthesia care unit (PACU) recovery time by 50%. This highlights the potential impact of astrocyte dysfunction on anesthetic sensitivity and robustness of EEG as a biomarker of anesthetic effect, including for pediatric patients with rare neurodevelopmental diseases.

    View details for DOI 10.1213/XAA.0000000000001910

    View details for PubMedID 39831714

  • Dispelling the myth: comparable duration and impact of research training for MD-PhD and PhD graduates JCI INSIGHT Mather, R., Rowell, T. R., Obuchowski, S., Walensky, L. D. 2024; 9 (15)

    Abstract

    The average time to degree for completing a life sciences PhD in the United States is longer for single-degree than dual-degree trainees, supporting a perception that the PhD training of MD-PhDs is less rigorous or fulsome. To determine whether degree format influences the duration and impact of graduate training, we analyzed data for the 2011-2016 graduates of 3 Harvard Medical School PhD programs. Linear mixed effects models were used to determine the association between degree type (MD-PhD vs. PhD) and research outcomes, including time to degree, time to thesis defense, and publications submitted during the PhD. Although pursuing an MD-PhD was associated with a 1.5-year shorter time to PhD degree, basing this calculation on the official PhD period does not account for completion of early PhD requirements, including research rotations and qualifying coursework, during the first 2 years of medical school. There was no association between degree format and total number of first-author or overall publications, though pursuing a dual degree was associated with increased impact metrics of published papers. The results highlight that despite the seemingly shorter PhD durations of MD-PhD graduates based on graduate program enrollment period, research training is on par with their single-degree peers, rendering MD-PhD graduates well equipped to become successful scientific investigators.

    View details for DOI 10.1172/jci.insight.182288

    View details for Web of Science ID 001288457900001

    View details for PubMedID 38917318

    View details for PubMedCentralID PMC11383590

  • Systemized approach to equipping medical students with naloxone: a student-driven initiative to combat the opioid crisis BMC MEDICAL EDUCATION Saberi, S. A., Moore, S., Li, S., Mather, R., Daniels, M. B., Shahani, A., Barreveld, A., Griswold, T., Mcguire, P., Connery, H. S. 2024; 24 (1): 241

    Abstract

    Naloxone is an effective and safe opioid reversal medication now approved by the U.S. Food and Drug Administration (FDA) for use with or without a prescription. Despite this, naloxone dissemination lags at a time when U.S. opioid-related mortality expands. The authors proposed distributing naloxone to all U.S. medical students using established statewide standing prescription orders for naloxone, eliminating the financial burden of over-the-counter costs on students and streamlining workflow for the pharmacy. By focusing naloxone distribution on medical students, we are able to capitalize on a group that is already primed on healthcare intervention, while also working to combat stigma in the emerging physician workforce.Beginning August 2022, the authors established a partnership between Harvard Medical School (HMS) and the outpatient pharmacy at Brigham and Women's Hospital (BWH) to facilitate access to naloxone for HMS medical students. BWH developed a HIPAA-secure electronic form to collect individual prescription information. BWH pharmacists processed submissions daily, integrating the naloxone prescription requests into their workflow for in-person pick-up or mail-order delivery. The electronic form was disseminated to medical students through a required longitudinal addiction medicine curriculum, listserv messaging, and an extracurricular harm reduction workshop.Over the 2022-2023 academic year, 63 medical students obtained naloxone kits (two doses per kit) through this collaboration.We propose that medical schools advocate for a hospital pharmacy-initiated workflow focused on convenience and accessibility to expand naloxone access to medical students as a strategy to strengthen the U.S. emergency response and prevention efforts aimed at reducing opioid-related morbidity and mortality. Expansion of our program to BWH internal medicine residents increased our distribution to over 110 healthcare workers, and efforts to expand the program to other BWH training programs and clinical sites such as the emergency department and outpatient infectious disease clinics are underway. With more than 90,000 medical students in the U.S., we believe that widespread implementation of targeted naloxone training and distribution to this population is an accessible approach to combating the public health crisis of opioid-related overdoses.

    View details for DOI 10.1186/s12909-024-05221-8

    View details for Web of Science ID 001184599800001

    View details for PubMedID 38448949

    View details for PubMedCentralID PMC10916177

  • Development and multicentre validation of the FLEX score: personalised preoperative surgical risk prediction using attention-based ICD-10 and Current Procedural Terminology set embeddings. British journal of anaesthesia Liu, R., Stone, T. A., Raje, P., Mather, R. V., Santa Cruz Mercado, L. A., Bharadwaj, K., Johnson, J., Higuchi, M., Nipp, R. D., Kunitake, H., Purdon, P. L. 2024

    Abstract

    BACKGROUND: Preoperative knowledge of surgical risks can improve perioperative care and patient outcomes. However, assessments requiring clinician examination of patients or manual chart review can be too burdensome for routine use.METHODS: We conducted a multicentre retrospective study of 243 479 adult noncardiac surgical patients at four hospitals within the Mass General Brigham (MGB) system in the USA. We developed a machine learning method using routinely collected coding and patient characteristics data from the electronic health record which predicts 30-day mortality, 30-day readmission, discharge to long-term care, and hospital length of stay.RESULTS: Our method, the Flexible Surgical Set Embedding (FLEX) score, achieved state-of-the-art performance to identify comorbidities that significantly contribute to the risk of each adverse outcome. The contributions of comorbidities are weighted based on patient-specific context, yielding personalised risk predictions. Understanding the significant drivers of risk of adverse outcomes for each patient can inform clinicians of potential targets for intervention.CONCLUSIONS: FLEX utilises information from a wider range of medical diagnostic and procedural codes than previously possible and can adapt to different coding practices to accurately predict adverse postoperative outcomes.

    View details for DOI 10.1016/j.bja.2023.11.039

    View details for PubMedID 38184474

  • <i>Paraburkholderia</i> symbionts isolated from <i>Dictyostelium discoideum</i> induce bacterial carriage in other <i>Dictyostelium</i> species PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES Mather, R., Larsen, T. J. J., Brock, D. A. A., Queller, D. C. C., Strassmann, J. E. E. 2023; 290 (2003): 20230977

    Abstract

    The social amoeba Dictyostelium discoideum engages in a complex relationship with bacterial endosymbionts in the genus Paraburkholderia, which can benefit their host by imbuing it with the ability to carry prey bacteria throughout its life cycle. The relationship between D. discoideum and Paraburkholderia has been shown to take place across many strains and a large geographical area, but little is known about Paraburkholderia's potential interaction with other dictyostelid species. We explore the ability of three Paraburkholderia species to stably infect and induce bacterial carriage in other dictyostelid hosts. We found that all three Paraburkholderia species successfully infected and induced carriage in seven species of Dictyostelium hosts. While the overall behaviour was qualitatively similar to that previously observed in infections of D. discoideum, differences in the outcomes of different host/symbiont combinations suggest a degree of specialization between partners. Paraburkholderia was unable to maintain a stable association with the more distantly related host Polysphondylium violaceum. Our results suggest that the mechanisms and evolutionary history of Paraburkholderia's symbiotic relationships may be general within Dictyostelium hosts, but not so general that it can associate with hosts of other genera. Our work further develops an emerging model system for the study of symbiosis in microbes.

    View details for DOI 10.1098/rspb.2023.0977

    View details for Web of Science ID 001032010300010

    View details for PubMedID 37464760

    View details for PubMedCentralID PMC10354463

  • Where Are the Bacteria? Using Photos of Skin Samples to Test Hypotheses AMERICAN BIOLOGY TEACHER Mather, R., Jefferson, C., Sherpa, R., Dzikunu, C., Brock, D., Queller, D., Strassmann, J. 2022; 84 (6): 347-352